Zevra Therapeutics, Inc.ZVRANASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, above historical average.
Left:
||||
Free cash flow yield
Latest
-18.06%
↑ 68% above average
Average (9y)
-56.56%
Historical baseline
Range
High:3.99%
Low:-211.43%
CAGR
+2.9%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -18.06% | -24.0% |
| 2023 | -14.57% | -22.6% |
| 2022 | -11.88% | -398.0% |
| 2021 | 3.99% | +190.1% |
| 2020 | -4.42% | +97.9% |
| 2019 | -211.43% | -24.4% |
| 2018 | -169.90% | -210.4% |
| 2017 | -54.73% | +22.5% |
| 2016 | -70.63% | -406.6% |
| 2015 | -13.94% | - |